.png)
.png)
Professor of Medicine, Head of the Israeli National Center for Antibiotic Resistance, Chief of the Division of Epidemiology
Israel Ministry of Health, Israel
Disclosure(s): Allecra Therapeutics: Advisor/Consultant; MSD: Advisor/Consultant; Nabriva: Advisor/Consultant; Pfizer: Advisor/Consultant; Qpex Pharmaceuticals: Advisor/Consultant; Roche: Advisor/Consultant; Shinogi: Advisor/Consultant; Spero Therapeutics: Advisor/Consultant
Yehuda Carmeli, MD, MPH is the director of the National Institute for Antibiotic Resistance and Infection Control in the Israeli Ministry of Health and Professor in the Sackler Faculty of Medicine, Tel Aviv University. He attended medical school at Ben Gurion University in Israel and received a master's degree from Harvard School of Public Health. He completed residency in medicine at Hadassah University Hospital, Jerusalem in Israel, clinical fellowship in medicine at Massachusetts General Hospital in Boston, and clinical and research fellowships in infectious diseases at Beth Israel Deaconess Medical Center in Boston, MA. His primary research interest is the epidemiology of antibiotic resistance. Dr. Carmeli is the author of over 350 peer-reviewed research articles. Dr. Carmeli is the recipient of the Finland research award of the Massachusetts Infectious Disease Society, and the John T. Smith award on research of new quinolones, the ICAAC program award for Pathogenesis of Microbial Diseases, the Society of Healthcare Epidemiology (SHEA) Mentor Award, and the Dutch Working Party on Antibiotic Policy (SWAB) award. He is the recipient of multiple national and international research grants and the leading investigator of multiple research projects.